期刊文献+

人端粒酶逆转录酶诱导的猪肝细胞初步鉴定 被引量:4

Characterization of porcine hepatocytes transfected with human catalytic subunit of telomerase reverse transcriptase(hTERT)
下载PDF
导出
摘要 目的观察应用四步灌流法分离后原代猪肝细胞的数量和活力,初步鉴定人端粒酶逆转录酶(hTERT)诱导的猪肝细胞的生物学特性。方法四步灌流法分离12只猪肝脏组织中的猪肝细胞,采用锥虫蓝拒染法测定其肝实质细胞数量和活力;将含hTERT真核表达的载体转染到原代猪肝细胞,经G418硫酸盐筛选,获得耐药性的猪肝细胞克隆并传代3代。观察原代猪肝细胞和hTERT诱导后的猪肝细胞的形态,检测两种猪肝细胞不同时期培养上清液中白蛋白、尿素氮的浓度。结果每只肝脏的肝细胞产量约为2.0×1010个,具有活力的肝细胞所占百分比为(95.5±3.2)%。原代猪肝细胞和hTERT诱导的猪肝细胞培养上清中分泌白蛋白和尿素氮在前3天无统计学差异(P>0.05),第4、5天差异有统计学意义(P<0.05)。结论四步灌流法分离获取的猪肝细胞产量高、功能活性好。hTERT诱导的猪肝细胞具有正常肝细胞的基本功能,可作为生物人工肝及细胞移植等的理想的细胞源。 Objective To assess the yield and vriability of porcine primary hepatocytes separated by a modified four-step collagenase method; and try to immortalize porcine hepatocytes by transfection of human telomerase reverse transcriptase (hTERT)gene. Methods Porcine primary hepatocytes were obtained from Chinese experimental miniature pigs using a modified four-step collagenase perfusion method, the yield and viability were determined by trypan blue exclusion test. The cells were transfected with hTERT cloned in a eukaryotic expression plasmid. The morphology of cultured porcine hepatocytes and transfected porcine hepatocytes was observed by optical microscope. The concentrations of albumin and BUN in the supernatant in the culture media were determined. Results The average yield of porcine hepatocytes was 2.0×10^10cells per liver with an average viability of (95.5±3.2)%. Two cloned porcine hepatocytes was obtained by G418 selection, and expanded by 3 passages. There were no significant differences in albumin secretion and urea synthesis in the first three days between the porcine primary hepatocytes and transfected porcine hepatocytes (P〉0.05), but there were significant differences in the albumin secretion and urea synthesis 3 days later (P〈0.05). Conclusion Porcine hepatocytes can be harvested with high yields using the modified four-step collagenase perfusion method. The transfected porcine hepatocytes maintain the properties of primary hepatocytes. This generation of new porcine hepatocytes may be applied for the development of bioartifical liver devices and hepatocytes transplantation.
出处 《浙江医学》 CAS 2006年第2期103-105,109,共4页 Zhejiang Medical Journal
基金 国家863重大专项(2003AA205150) 十五攻关课题(2004BA706B02-01)
关键词 人端粒酶逆转录酶 猪肝细胞 生物人工肝支持系统 永生化 Human catalytic subunit of telomerase Porcine hepatocyte Support system of bioartificial liver Immortalization
  • 相关文献

参考文献1

二级参考文献16

  • 1[1]Emond JC, Whitington PF, Thistlethwaite JR, Cherqui D, Alonso EA, Woodle IS, Vogelbach P, Busse-Henry SM, Zucker AR,Broelsch CE. Transplantation of two patients with one liver. Ann Surg 1990; 212:14-22
  • 2[2]Shaw BW. More questions than answers. Liver Transplant Surg 1995; 1:404-407
  • 3[3]Everhart JE, Lombardero M, Detre KM, Zetterman RK, Wiesner RH, Lake JR, Hoofnagle JH. Increased waiting time for liver transplantation results in higher mortality. Transplantation 1997; 64:1300-1306
  • 4[4]Bilsuttil W, Klintmalm B. Transplantation of the liver Philadelphia. W. B. Saunders Company 1996:861
  • 5[5]Emond JC, Whitington PF, Thistlethwaite JR, Alonso EM,Broelsch CE. Reduced-size orthotopic liver transplantation: use in the management of children with chronic liver disease.Hepatology 1989; 10:867-872
  • 6[6]Friedman AL. Why bioartificial liver support remains the holy grail. ASAIO 1998; 44:241-243
  • 7[7]Kamihira M, Yamada K, Hamamoto R, Iijima S. Speroid formation of hepatocytes using synthetic polymer. Ann NY Acad Sci 1997; 831:398-407
  • 8[8]Sussman NL, Gislason GT, Conlin CA, Kelly JH. The Hepatix extracorporeal liver assist device: Initial clinical experience. Artif Organs 1994; 18:390-396
  • 9[9]Dixit V. Development of a bioartificial liver using isolated hepatocytes. Artif Organs 1994; 18:371-384
  • 10[10]Hui T, Rozga J, Demetriou AA. Bioartificial liver support. J Hepatobiliary Surg 2001; 8:1-15

共引文献25

同被引文献45

  • 1李跃萍,宋丽萍,邱曙东.慢病毒载体在肿瘤基因治疗中的应用[J].现代肿瘤医学,2006,14(12):1614-1617. 被引量:17
  • 2Demetriou AA, Brown RS Jr, Busuttil RW, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg, 2004,239 : 660-670.
  • 3Li LJ, Du WB, Zhang YM, et al. Evaluation of a bioartificial liver based on a nonwoven fabric bioreactor with porcine hepatocytes in pigs. J Hepatol, 2006,44:317-324.
  • 4Park JK, Kim BH, Han YS, et al. The effect of telomerase expression on the escape from M2 crisis in virus transformed human retinal pigment epithelial cells. Exp Mol Med, 2002, 34: 107-113.
  • 5Fukaya K, Asahi S, Nagamori S, et al. Establishment of a human hepatocyte line (OUMS-29) having CYP 1A1 and 1A2 activities from fetal liver tissue by transfection of SV40 LT. In Vitro Cell Dev Biol Anim, 2001,37: 266-26%
  • 6Liu J, Jauregui HO, Faris RA, et al. Growth and metabolic activity of immortalized porcine hepatocytes in extracorporeal hollow-fiber liver assist devices. Artif Organs, 2001, 25: 539-545.
  • 7Greider C W. Telomere length regulation [ J]. Annu Rev Biochem, 1996,65:337-365.
  • 8Kim N W, Piatyszek M A , Prowse K R, et al. Specific association of human telomerase activity with immortal cells and cancer[ J]. Science, 1994,266 (5193 ) : 2011-2015.
  • 9Stampfer M R, Yaswen P. Human epithelial cell immortalization as a step in carcinogenesis [ J ]. Cancer Lett, 2003,194 (2) : 199-208.
  • 10Fiedler W, Reinicke D, Aurich I-I, et al. In vitro immortalisation of porcine hepatocytes by transfection with the gene for the human catalytic subunit of telomerase reverse transcriptase (hTERT) [ J]. J Hepatol, 2004, 40(Suppl 1 ) : 102-109.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部